Publications by authors named "Ann Daly"

Claim this Profile
I
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related Mortality.
Carolin V Schneider, Stefan Gross, Sriram Balasubramani, Petra Tomanová, Christina Schrader, Ann K Daly

Clin Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways.
Marijana Vujkovic, David E Kaplan, Jonas Ghouse, Bao-Li Loza, Joseph Brancale, Ann K Daly

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics in 2023: Big studies, big results, big implications, big responsibilities: Editorial.
Ann K Daly, Andrew A Somogyi

Br J Clin Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and Genomic Approaches to the Study of Drug-Induced Liver Injury.
Ann K Daly

Liver Int· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis.
Silvia Sabatini, Partho Sen, Fabrizia Carli, Samantha Pezzica, Chiara Rosso, Ann Daly

Cell Rep Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogene expression during progression of metabolic dysfunction-associated steatotic liver disease: Studies on mRNA and protein levels and their relevance to drug treatment.
Olivier Govaere, Simon J Cockell, Michalina Zatorska, Kristy Wonders, Dina Tiniakos, Ann K Daly

Biochem Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PharmVar GeneFocus: CYP4F2.
Pablo Zubiaur, Cristina Rodríguez-Antona, Erin C Boone, Ann K Daly, Evangelia Eirini Tsermpini

Clin Pharmacol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the current situation of pharmacogenomics in terms of educational and healthcare needs in Egypt and Lebanon.
Sahar M El-Gowilly, Heba A Metwaly, Dalia Makhlouf, Nehal Elmansoury, Salwa A Abuiessa, Ann Daly

Pharmacogenomics· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA-Update with genetic correlations.
Herbert L Bonkovsky, Marwan Ghabril, Paola Nicoletti, Andrew Dellinger, Robert J Fontana, Ann K Daly

Liver Int· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry.
Tae-Hwi Schwantes-An, John B Whitfield, Guruprasad P Aithal, Stephen R Atkinson, Ramon Bataller, Ann K Daly

Hepatol Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD).
Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, Fiona Oakley, Christian Trautwein, Ann K Daly

Nat Metab· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of , , , and Variants to MASLD Severity in an Egyptian Population.
Nehal Elmansoury, Ahmed A Megahed, Ahmed Kamal, Nefertiti El-Nikhely, Marina Labane, Ann K Daly

Genes (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Genetic Variations on Thromboembolic Risk in Saudis with Sickle Cell Disease.
Mohammad A Alshabeeb, Deemah Alwadaani, Farjah H Al Qahtani, Salah Abohelaika, Mohsen Alzahrani, Ann K Daly

Genes (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control study.
Jane I Grove, Camilla Stephens, M Isabel Lucena, Raúl J Andrade, Sabine Weber, Ann K Daly

Diagn Progn Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-induced liver injury due to nitrofurantoin: Similar clinical features, but different HLA risk alleles in an independent cohort.
Ann K Daly, Einar S Bjornsson, M Isabel Lucena, Raul J Andrade, Guruprasad P Aithal

J Hepatol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort" [J Hepatol (2020) 505-515].
Quentin M Anstee, Rebecca Darlay, Simon Cockell, Marica Meroni, Olivier Govaere, Ann K Daly

J Hepatol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics in practice: a review and implementation guide.
Danya Kabbani, Reem Akika, Ahmed Wahid, Ann K Daly, Ingolf Cascorbi

Front Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress.
Ron Hn van Schaik, Vangelis G Manolopoulos, Ann K Daly, Mikko Niemi, Branka Zukic

Pharmacogenomics· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures.
Olivier Govaere, Megan Hasoon, Leigh Alexander, Simon Cockell, Dina Tiniakos, Ann K Daly

Nat Metab· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.
Paola Nicoletti, Andrew Dellinger, Yi Ju Li, Huiman X Barnhart, Naga Chalasani, Ann K Daly

Gastroenterology· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of Pharmacogenomics to the Safe Use of Antimicrobials.
Ann K Daly

Antibiotics (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics of drug-induced liver injury: Current knowledge and future prospects.
Ann K Daly

Clin Transl Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease.
Partho Sen, Olivier Govaere, Tim Sinioja, Aidan McGlinchey, Dawei Geng, Ann K Daly

iScience· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetics in drug disposition & drug therapy: symposium report of the 24 North American meeting of the International Society for the Study of Xenobiotics (ISSX).
Benjamin J Maldonato, Ana G Vergara, Jaydeep Yadav, Sarah M Glass, Erickson M Paragas, Ann K Daly

Drug Metab Rev· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics of the cytochromes P450: Selected pharmacological and toxicological aspects.
Ann K Daly

Adv Pharmacol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis